A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx
Business Trip
English - May 04, 2021 05:00 - 44 minutes - 30.8 MBEntrepreneurship Business Health & Fitness Mental Health psychedelics psychedelic psychedelic startups mental health wellness human flourishing Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Today's episode features Deborah Mash, founder and CEO of DemeRx, a clinical stage company developing ibogaine therapies to treat substance use disorders.
In this episode, we discuss:
The science, experience and the safety behind Ibogaine’s “neurochemical reset”Navigating US drug regulatory system and securing Intellectual PropertyDeborah’s 30 journey through Amsterdam, Miami and the Caribbean aiming to get Ibogaine therapy approvedPartnership with ATAI Life SciencesLinks to topics discussed in this episode:
Deborah Mash
DemeRx
Ibogaine
Noribogaine
Tabernanthe Iboga
Bwiti Religion
Howard Lotsof
Serotonergics
Lambarene - promoted as a mental and physical stimulant
Habenula
Addiction Expert Gabor Maté
Read the transcript here.
Watch episode 8 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh
Find us at businesstrip.fm
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional music by Medita by Crowander, Two Feet by Muted Circus, and Rain On Me by JBlanked.